Leaflet BENEFICIN 250UI / 5000UI / g ointment


Indicated for: bacterial infections

Route of administration: cutaneous

Substance: bacitracin + neomycin (antibacterial antibiotic + aminoglycoside antibiotic)

ATC: D06AX04 (Dermatologicals | Antibiotics for topical use | Other antibiotics for topical use)

Bacitracin+neomycin is a combination of antibiotics used for the topical treatment of minor skin infections such as cuts, burns, and abrasions. Bacitracin works by inhibiting bacterial cell wall synthesis, while neomycin interferes with bacterial protein synthesis, providing broad antibacterial coverage.

This combination is available as an ointment and is applied directly to the skin, usually 1-3 times daily, depending on the severity of the infection. It is effective against gram-positive and gram-negative bacteria and is widely used in wound care.

Common side effects include local irritation, redness, and a burning sensation at the application site. In rare cases, prolonged use may lead to allergic reactions or the development of bacterial resistance. It is important for patients to follow usage instructions and avoid excessive application.

Bacitracin+neomycin is an effective therapeutic option for the prevention and treatment of minor skin infections, contributing to rapid healing and the prevention of complications.

General data about BENEFICIN 250UI / 5000UI / g

  • Substance: bacitracin + neomycin
  • Commercial code: W71884001
  • Concentration: 250UI / 5000UI / g
  • Pharmaceutical form: ointment
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: ANTIBIOTICE S.A. - ROMANIA
  • Holder: ANTIBIOTICE S.A. - ROMANIA
  • Number: 16592/2026/01
  • Shelf life: 3 years-after packing for marketing;after the first opening of the tube-4 months